South Korea - Hospital Average Length of Stay for Carcinoma in Situ
Since 2014, South Korea Hospital Average Length of Stay for Carcinoma in Situ jumped by 0.8% year on year. With 7.5 Days in 2019, the country was ranked number 1 among other countries in Hospital Average Length of Stay for Carcinoma in Situ. Slovakia, Latvia and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +10.6% per year, while New Zealand recorded the worst performance at -8% per year.
Loading...
| Date | Days |
|---|---|
| 2019 | 7.50 |
| 2018 | 7.70 |
| 2017 | 6.90 |
| 2016 | 7.60 |
| 2015 | 7.10 |
Download all data from 1996 to 2019
How does South Korea rank in Hospital Average Length of Stay for Carcinoma in Situ?
| # | 33 Countries | Days | Last | YoY | 5‑years CAGR | |
|---|---|---|---|---|---|---|
| 1 |
#1
South Korea
|
7.50 | 2019 | -2.6 % | +0.8 % | View data |
| 2 |
#2
Slovakia
|
5.40 | 2019 | +0.0 % | +0.4 % | View data |
| 3 |
#3
Latvia
|
5.30 | 2019 | -1.9 % | +0.4 % | View data |
| 4 |
#4
Germany
|
5.20 | 2019 | -1.9 % | -1.5 % | View data |
| 5 |
#5
Israel
|
4.80 | 2019 | +6.7 % | +0.8 % | View data |